FAT4 expression was significantly and negatively correlated with several immunoinhibitors in HCC, including LAG3, CTLA4, CD160, and PVRL2 (p < 0.05; Fig. 7a,b,c,d,e). This evidence concerns the gene CD160 and hepatocellular carcinoma.